ES2005752A6 - Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas. - Google Patents

Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas.

Info

Publication number
ES2005752A6
ES2005752A6 ES8703788A ES8703788A ES2005752A6 ES 2005752 A6 ES2005752 A6 ES 2005752A6 ES 8703788 A ES8703788 A ES 8703788A ES 8703788 A ES8703788 A ES 8703788A ES 2005752 A6 ES2005752 A6 ES 2005752A6
Authority
ES
Spain
Prior art keywords
carbacephalosporins
trifluoromethylsulfonyloxy
carbacefalosporinas
preparation
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8703788A
Other languages
English (en)
Inventor
David Albert Evans
Eric Brian Sjogren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of ES2005752A6 publication Critical patent/ES2005752A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO ASIMETRICO PARA LA PREPARACION DE 1-CARBOCEFALOSPORINAS DE FORMULA (X)DONDE R2 Y R6 TIENEN LOS SIGNIFICADOS MENCIONADOS EN LA MEMORIA, QUE COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (B)CON UNA BASE CON IMPEDIMENTO ESTERICO.
ES8703788A 1985-07-17 1987-12-31 Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas. Expired ES2005752A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/755,982 US4665171A (en) 1985-07-17 1985-07-17 Process and intermediates for β-lactam antibiotics

Publications (1)

Publication Number Publication Date
ES2005752A6 true ES2005752A6 (es) 1989-03-16

Family

ID=25041514

Family Applications (2)

Application Number Title Priority Date Filing Date
ES8600341A Expired ES2000516A6 (es) 1985-07-17 1986-07-16 Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas
ES8703788A Expired ES2005752A6 (es) 1985-07-17 1987-12-31 Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES8600341A Expired ES2000516A6 (es) 1985-07-17 1986-07-16 Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas

Country Status (21)

Country Link
US (1) US4665171A (es)
EP (2) EP0209352B1 (es)
JP (2) JPH0762015B2 (es)
KR (1) KR900005257B1 (es)
CN (1) CN1015178B (es)
AR (1) AR243186A1 (es)
AT (2) ATE63118T1 (es)
AU (2) AU595216B2 (es)
CA (1) CA1310323C (es)
DE (2) DE3679002D1 (es)
DK (2) DK173456B1 (es)
ES (2) ES2000516A6 (es)
GR (1) GR861857B (es)
HU (2) HU201931B (es)
IE (1) IE58997B1 (es)
IL (1) IL79420A (es)
NZ (1) NZ216871A (es)
PT (1) PT82989B (es)
RU (1) RU1794079C (es)
SU (1) SU1579460A3 (es)
ZA (1) ZA865274B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870169A (en) * 1985-07-17 1989-09-26 President And Fellows Of Harvard College Intermediates for beta-lactam antibiotics
US4673737A (en) * 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof
US4734498A (en) * 1986-07-10 1988-03-29 Eli Lilly And Company 3β-succinimidoazetidinones as chiral intermediates
CA1323370C (en) * 1986-09-12 1993-10-19 Davis H. Crater Fluorochemical oxazolidinones
US4782144A (en) * 1987-09-14 1988-11-01 Eli Lilly And Company 1-carba(dethia)-3-hydroxy-3-cephem ester crystalline and crystalline solvate thereof
US5019571A (en) * 1988-01-25 1991-05-28 Eli Lilly And Company 1-carbacephalosporin antibiotics
US4855418A (en) 1988-03-23 1989-08-08 Eli Lilly And Company Process for production of ceophalosporins
US4820832A (en) * 1988-03-23 1989-04-11 Eli Lilly And Company Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins
EP0345999A1 (en) * 1988-06-06 1989-12-13 Eli Lilly And Company Process for intermediates to 1-carba(1-dethia)-3-cephem-4-carboxylic acids
US4885362A (en) * 1988-06-06 1989-12-05 Eli Lilly And Company Azetidinone intermediates for 1-carba(dethia)caphalosporins
EP0345998A1 (en) * 1988-06-06 1989-12-13 Eli Lilly And Company Process and intermediates for beta-lactam antibiotics
ATE104977T1 (de) * 1988-06-22 1994-05-15 Lilly Co Eli Zwischenprodukt fuer 1-carba(dethia)cephalosporin.
KR0169096B1 (ko) * 1988-10-11 1999-01-15 리로이 휘테커 카바세팔로스포린의 아제티디논 중간체 화합물 및 제조방법
US5453503A (en) * 1988-10-11 1995-09-26 Eli Lilly And Company Azetidinone intermediates to carbacephalosporins and process
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
US4931556A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-(2-furyl)eth-1-yl)-methoxycarbonylmethyl-azetidin-2-one and malic acid salts thereof
JPH02252648A (ja) * 1989-03-27 1990-10-11 Naomi Iwagou イオン溶出燒結体
US4992545A (en) * 1989-09-20 1991-02-12 Eli Lilly And Company Process for preparing 4-substituted azetidinones
US5106475A (en) * 1989-09-20 1992-04-21 Eli Lilly And Company Process for preparing 4-substituted azetidinones
US5030725A (en) * 1990-02-06 1991-07-09 Eli Lilly And Company Method of resolving cis 3-amino-4-[2-(2-furyl)eth-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one using (-)-DAG
US5051502A (en) * 1990-06-06 1991-09-24 University Of Notre Dame Du Lac Rhodium catalyzed cyclization process for bicyclic β-lactams
ES2140384T3 (es) * 1990-09-13 2000-03-01 Lilly Co Eli Intermedios para 1-carbacefalosporinas y procedimiento para su preparacion.
US5089610A (en) * 1991-04-25 1992-02-18 Eli Lilly And Company Ring-closure method for 1-carbacephalosporin six-membered ring
US5521307A (en) * 1992-02-18 1996-05-28 Eli Lilly And Company Methods and compounds for the preparation of carbacephems
WO1997030707A1 (en) 1996-02-23 1997-08-28 Eli Lilly And Company NON-PEPTIDYL VASOPRESSIN V1a ANTAGONISTS
EP1147422A1 (en) 1999-01-27 2001-10-24 Pharmacia & Upjohn Company Assays for modulators of "elongation factor p" activity
JP4916929B2 (ja) * 2007-03-23 2012-04-18 ヤマハ発動機株式会社 直交型ロボット
CA2711957C (en) 2007-10-11 2019-03-19 The Regents Of The University Of California Use of inhibitors of n-acylethanolamine-hydrolyzing acid amidase as anti-inflamatory medicaments
PL3351104T3 (pl) 2010-07-01 2021-06-14 Azevan Pharmaceuticals, Inc. Związki do stosowania w leczeniu okresowych zaburzeń wybuchowych
WO2014144547A2 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
WO2014144836A2 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
SG10202001065SA (en) 2014-03-28 2020-04-29 Azevan Pharmaceuticals Inc Compositions and methods for treating neurodegenerative diseases
US20190321363A1 (en) * 2016-06-20 2019-10-24 Dr. Reddy's Laboratories Limited Process for the preparation of elagolix sodium and its polymorph
CN112500361B (zh) * 2020-12-27 2023-05-12 甘肃瀚聚药业有限公司 一种(s)-4-苯基-2-恶唑烷酮的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226866A (en) * 1972-11-06 1980-10-07 Merck & Co., Inc. Novel antibiotic analogues of cephalosporins
US4166816A (en) * 1975-05-05 1979-09-04 Smithkline Corporation Methods and intermediates for preparing cis-4-oxoazetidine intermediates
US4200572A (en) * 1975-09-03 1980-04-29 Smithkline Corporation Substituted azetidinones
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
US4174316A (en) * 1978-08-14 1979-11-13 Merck & Co., Inc. 4-Iodomethylazetidin-2-one
US4472576A (en) * 1982-12-03 1984-09-18 Merck & Co., Inc. Processes for the production of antibiotic 1-oxadethiacephalosporins
US4502994A (en) 1982-12-09 1985-03-05 Hoffmann-La Roche Inc. Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate
US4751299A (en) * 1983-11-18 1988-06-14 Takeda Chemical Industries, Ltd. Optically active β-lactams and method of their production
US4673737A (en) 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof

Also Published As

Publication number Publication date
HU201931B (en) 1991-01-28
PT82989B (pt) 1989-01-30
EP0362902A2 (en) 1990-04-11
JPS6242985A (ja) 1987-02-24
DE3650474D1 (de) 1996-02-29
AU4793490A (en) 1990-05-10
KR870001193A (ko) 1987-03-12
ZA865274B (en) 1988-02-24
US4665171A (en) 1987-05-12
CA1310323C (en) 1992-11-17
DK173456B1 (da) 2000-11-27
DK335686A (da) 1987-02-25
AR243186A1 (es) 1993-07-30
EP0209352B1 (en) 1991-05-02
ATE133172T1 (de) 1996-02-15
CN86104783A (zh) 1987-02-04
IE861900L (en) 1987-01-17
EP0362902A3 (en) 1990-08-01
PT82989A (en) 1986-08-01
EP0209352A3 (en) 1988-04-20
ATE63118T1 (de) 1991-05-15
JPH0762015B2 (ja) 1995-07-05
HK1007140A1 (en) 1999-04-01
HU906465D0 (en) 1991-04-29
JPH07300476A (ja) 1995-11-14
RU1794079C (ru) 1993-02-07
DE3679002D1 (de) 1991-06-06
SU1579460A3 (ru) 1990-07-15
NZ216871A (en) 1989-10-27
DK335686D0 (da) 1986-07-15
ES2000516A6 (es) 1988-03-01
JP2634775B2 (ja) 1997-07-30
AU619938B2 (en) 1992-02-06
IE58997B1 (en) 1993-12-15
AU595216B2 (en) 1990-03-29
HUT41786A (en) 1987-05-28
CN1015178B (zh) 1991-12-25
DE3650474T2 (de) 1996-06-13
AU6016686A (en) 1987-01-22
IL79420A (en) 1992-01-15
GR861857B (en) 1986-11-18
EP0209352A2 (en) 1987-01-21
DK16096A (da) 1996-02-15
KR900005257B1 (ko) 1990-07-21
EP0362902B1 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
ES2005752A6 (es) Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas.
PT82990B (pt) Processo para a preparacao de antibioticos da classe das cefalosporinas
PL240367A1 (en) Method of obtaining novel 9-/1-or 3-monoacyloxy or els 1,3-diacyloxy-2-propoxymethyl/-purines or their addition salts with acids
ES556081A0 (es) Procedimiento para preparar acido tereftalico puro
YU221889A (en) Process for producing new pharmaceutical mixture
ATE40992T1 (de) Verfahren zur herstellung beweglicher pasten waschaktiver alpha-sulfofettsaeureestersalze hohen feststoffgehalts.
AU541323B2 (en) Amine salts of 6-beta-halopenicillanic acids
AU526822B2 (en) Recovery of salts of anthraquinonedisulphonic acids
AU1898883A (en) Phosphorus-containing acetic acid derivatives
AU564919B2 (en) 5-thioxo-2-imidazolinyl benzioc acids, esters, salts and related compounds
AU1481583A (en) 5-oxo-2-pyrrolidine propanoic acid derivatives
EP0204286A3 (en) Process for preparing trans-beta-benzoylacrylic acid ester
AU1169583A (en) 1,4,dihydropyridine-3,5-dicarboxylic acid esters
ES549294A0 (es) Procedimiento para preparar esteres de cefalosporinas
FI862043A7 (fi) Menetelmä 2-tiokromenyylideeniasetetikkaesterien valmistamiseksi.
AU561755B2 (en) Sulfonic acid ester derivatives and process for preparing same
AU531659B2 (en) (+)-(3-methyl-4-oxo - 5n-piperidinothiazolidin-2-ylidene) acetic acid esters
AU543555B2 (en) Strong organic acid polyelectrolyte salts
GR3036631T3 (en) Preparation and utilisation of pure enantiomers of 8-halogen-6-hydroxyoctanoic acid, their alkyl esters and their salts with pure enantiomers of alpha-methyl-benzylamines
AU1259488A (en) Process for the preparation of 5-hydroxydiprafenone and its acid addition salts
AU2127483A (en) Methods of using strong acids modified with acid solutions
ES544783A0 (es) Metodo para la preparacion de esteres de o (2,6-diclorofenilamino) acido fenilacetico.
FI880035A7 (fi) Menetelmä kiteisen aminosuojatun beeta-bent-syyli-L-asparagiinihapon valmistamiseksi.
AU2231583A (en) Enamine derivatives of phosphonic acid esters
ES8708219A1 (es) Un procedimiento para la preparacion de oxetanonas